Status
Conditions
Treatments
About
The goal of this observational study is to identify early signs of poor neurodevelopmental outcome by performing specific neurological, neurophysiological and neuroimaging assessments in newborns with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia.
The main questions it aims to answer are:
Participants will be involved in serial assessment:
After discharge study population will perform:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:All infants with gestational age ≥ 35 weeks and with a body weight ≥ 1800 g were considered eligible, if they satisfied the following criteria:
All enrolled infants underwent therapeutic hypothermia according to the international guideline for 72 hours.
Exclusion Criteria:
Infants with:
70 participants in 1 patient group
Loading...
Central trial contact
Domenico M Romeo, MD,PHD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal